Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 639

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 7
Chunk 639
---
), $45 million pre-tax ($35 million after-tax) and $135 million pre-tax ($103 million after-tax) for the years ended December 31, 2024, December 31, 2023 and December 31, 2022, respectively.

Note 6 – Earnings Per Share

Accounting Policy. The Company computes basic earnings per share using the weighted-average number of unrestricted common and deferred shares outstanding. Diluted earnings per share also includes the dilutive effect of outstanding employee stock options and restricted stock using the treasury stock method and the effect of strategic performance shares.

Basic and diluted earnings per share were computed as follows:

For the Years Ended December 31,202420232022(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$3,434 $3,434 $5,164 $5,164 $6,704 $6,704 Shares:Weighted average280,294 280,294 293,892 293,892 309,546 309,546 Common stock equivalents2,924 2,924 2,990 2,990 3,519 3,519 Total shares280,294 2,924 283,218 293,892 2,990 296,882 309,546 3,519 313,065 Earnings per share$12.25 $(0.13)$12.12 $17.57 $(0.18)$17.39 $21.66 $(0.25)$21.41 

The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:For the Years Ended December 31,(In millions)202420232022Anti-dilutive options1.1 0.9 1.0 

69